摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

propofol-glucuronide

中文名称
——
中文别名
——
英文名称
propofol-glucuronide
英文别名
propofol O-glucuronide;(2S,3S,4S,5R)-6-[2,6-di(propan-2-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
propofol-glucuronide化学式
CAS
——
化学式
C18H26O7
mdl
——
分子量
354.4
InChiKey
JZSJIASBMOIIKI-ODEDACCXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    116
  • 氢给体数:
    4
  • 氢受体数:
    7

ADMET

代谢
(2S,3S,4S,5R)-6-[2,6-二(丙-2-基)苯氧基]-3,4,5-三羟基氧杂环己烷-2-羧酸丙泊酚的人类已知代谢物。
(2S,3S,4S,5R)-6-[2,6-Di(propan-2-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a known human metabolite of propofol.
来源:NORMAN Suspect List Exchange

反应信息

  • 作为产物:
    描述:
    丙泊酚UDP-glucuronic acid 在 human UDP-glucuronosyltransferase 1A9 、 magnesium chloride 、 alamethicin 、 糖质酸-1,4-内酯 作用下, 生成 propofol-glucuronide
    参考文献:
    名称:
    Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches
    摘要:
    通过实验使用145种酚类化合物,并通过3D-QSAR方法分析,确定了人UGT1A9的催化选择性。UGT1A9是一种重要的膜结合酶,催化外源性物质的葡糖醛酸化反应。通过动力学分析确定了UGT1A9的催化效率。使用CoMFA和CoMSIA技术分析了定量结构活性关系。通过将葡糖醛酸化位点及其相邻的芳香环重叠,实现了底物结构的最大立体重叠。对于具有多个活性葡糖醛酸化位点的底物,每个位点被视为单独的底物。3D-QSAR分析产生了统计上可靠的模型,具有良好的预测能力(CoMFA:q2=0.548,r2=0.949,r pred 2=0.775;CoMSIA:q2=0.579,r2=0.876,r pred 2=0.700)。通过轮廓系数图阐明了底物中负责选择性差异的结构特征。将轮廓系数图叠加在UGT1A9的同源模型的催化口袋中,能够高度自信地识别UGT1A9的催化口袋。CoMFA/CoMSIA模型可以预测底物的选择性和UGT1A9的体外清除率。我们的发现还提供了理解UGT1A9功能和底物选择性的可能分子基础。
    DOI:
    10.1007/s11095-012-0666-z
点击查看最新优质反应信息

文献信息

  • Identification of Human UGT2B7 as the Major Isoform Involved in the<i>O</i>-Glucuronidation of Chloramphenicol
    作者:Mei Chen、Barbara LeDuc、Stephen Kerr、David Howe、David A. Williams
    DOI:10.1124/dmd.109.029900
    日期:2010.3
    Chloramphenicol (CP), a broad spectrum antibiotic, is eliminated in humans by glucuronidation. The primary UGT enzymes responsible for CP O -glucuronidation remain unidentified. We have previously identified the 3- O -CP (major) and 1- O -CP (minor) glucuronides by β-glucuronidase hydrolysis, liquid chromatography-tandem mass spectrometry, and 1D/2D H NMR. Reaction phenotyping for the glucuronidation of CP with 12 expressed human liver UGT isoforms has identified UGT2B7 as having the highest activity for 3- O - and 1- O -CP glucuronidation with minor contributions from UGT1A6 and UGT1A9. The kinetics of CP 3- O -glucuronidation by pooled human liver microsomes (HLMs) exhibited biphasic Michaelis-Menten kinetics with the apparent high-affinity K m1 and low-affinity K m2 values of 46.0 and 1027 μM, whereas expressed UGT2B7 exhibited Michaelis-Menten kinetics with the apparent K m value of 109.1 μM. The formation of 1- O -CP glucuronide by pooled HLM and expressed UGT2B7 exhibited substrate inhibition kinetics with apparent K m values of 408.2 and 115.0 μM, respectively. Azidothymidine (AZT) and hyodeoxycholic acid (substrates of UGT2B7) inhibited 3- O - and 1- O -CP glucuronidation in pooled HLMs. In 10 donor HLM preparations, both CP 3- O - and CP 1- O -glucuronidation showed a significant correlation with AZT glucuronidation (UGT2B7) ( r s = 0.85 and r s = 0.83, respectively) at 30 μM CP, whereas no significant correlation was observed between CP 3- O -glucuronidation and serotonin glucuronidation (UGT1A6) or propofol glucuronidation (UGT1A9) at this CP concentration. These results suggest that UGT2B7 is the primary human hepatic UDP-glucuronosyltransferase isoform catalyzing 3- O - and 1- O -CP glucuronidation with minor contributions from UGT1A6 and UGT1A9.
    氯霉素(CP)是一种广谱抗生素,在人体内通过葡糖醛酸化途径被清除。负责CP O-葡糖醛酸化的主要UGT酶仍然未被识别。我们之前通过β-葡糖醛酸苷酶解、液相色谱-串联质谱和1D/2D 1H NMR鉴定了3-O-CP(主要)和1-O-CP(次要)葡糖醛酸苷。对12种表达的人肝UGT同工酶的CP葡糖醛酸化反应表型进行鉴定,发现UGT2B7对3-O-和1-O-CP葡糖醛酸化活性最高,UGT1A6和UGT1A9有较小贡献。人肝微粒体(HLMs)中CP 3-O-葡糖醛酸化动力学呈双相米氏动力学,高亲和力Km1值和低亲和力Km2值分别为46.0μM和1027μM,而表达的UGT2B7呈现单相米氏动力学,Km值为109.1μM。人肝微粒体和表达的UGT2B7的1-O-CP葡糖醛酸苷形成呈现底物抑制动力学,Km值分别为408.2μM和115.0μM。叠氮胸苷(AZT)和猪胆酸(UGT2B7的底物)抑制了人肝微粒体中的3-O-和1-O-CP葡糖醛酸化。在10个供体的人肝微粒体中,30μM CP时,CP 3-O-和CP 1-O-葡糖醛酸化与AZT葡糖醛酸化(UGT2B7)显著相关(rs=0.85和rs=0.83),而CP 3-O-葡糖醛酸化与5-羟色胺葡糖醛酸化(UGT1A6)或丙泊酚葡糖醛酸化(UGT1A9)在此CP浓度下无显著相关性。这些结果表明,UGT2B7是催化3-O-和1-O-CP葡糖醛酸化的主要人肝UDP-葡糖醛酸基转移酶同工酶,UGT1A6和UGT1A9有较小贡献。
  • Validated assay for the evaluation of multiple glucuronidation activities in human liver microsomes via liquid chromatography-tandem mass spectrometry
    作者:Rong Shi、Yuanyuan Yang、Jie Zhong、Tianming Wang、Yueming Ma
    DOI:10.1039/c4ra10687c
    日期:——

    A faster and more accurate LC-MS/MS method was established for the activity determination of multiple UGT isoforms in HLMs.

    在人类肝微粒体中,建立了一种更快、更准确的LC-MS/MS方法,用于确定多种UGT同工酶的活性。
  • Yang, Jing; Zhang, Beibei; Qin, Zi Fei, International Journal of Clinical and Experimental Medicine, 2019, vol. 12, # 5, p. 4960 - 4971
    作者:Yang, Jing、Zhang, Beibei、Qin, Zi Fei、Zhang, Xiao Jian
    DOI:——
    日期:——
查看更多